Look like that announcement resulted in a few stained undies.
An ever improving cash position of a company gearing up for phase 3 trials is harder and harder to discredit I guess.
But good to see a contrarian argument was resolved and presented to investors in time for NASDAQ opening by the evening. Funny stuff...
Looking forward to news on Imagine extension. ( Im quite sure a response team has already figured out how to tackle a number of scenarios on that already)
All we need are those results to present to FDA for safety and tolerability and we should be off on a P3 for Huntingtons - if not an NDA. fingers crossed.
Look like that announcement resulted in a few stained undies. An...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.001(11.1%) |
Mkt cap ! $91.27M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.0¢ | 0.9¢ | $9.419K | 1.001M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 37 | 63876237 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 4097409 | 8 |
View Market Depth
| Last trade - 16.15pm 04/07/2025 (20 minute delay) ? |
| ATH (ASX) Chart |